Helen Quarles, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 402 W. Lake St., Friendship, WI 53934 Phone: 608-339-3331 |
Luann M. Livingston, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 402 W. Lake St., Friendship, WI 53934 Phone: 608-339-3331 |
Sharon Lee Mendez, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 201 S Park Ave, Friendship, WI 53934 Phone: 608-339-3361 Fax: 608-339-9468 |
News Archive
Drugmaker GlaxoSmithKline announced plans on Tuesday to donate 50 million doses of its H1N1 (swine flu) vaccine to the WHO for use in developing countries within the next few months, Reuters reports. "We expect to start receiving [the first of the H1N1 doses] at the end of the month or early December and that the full 50 million will come by the end of spring," WHO spokesman Gregory Hartl said, adding, "We hope it is the first of many donations."
Up to 40 percent of eyeglass wearers are interested in self-tinting lenses, according to an international Carl Zeiss Vision study of 5,800 eyeglass wearers. Yet despite high consumer interest, only about 20 percent of eyeglass wearers purchase self-tinting lenses. Many consumers hold back because they want lenses that darken and clear faster. To meet this need, ZEISS, a leader in precision optics for over 160 years, has introduced a new self-tinting lens called PhotoFusion.
Positively charged gold nanoparticles are usually toxic to cells, but cancer cells somehow manage to avoid nanoparticle toxicity. Mayo Clinic researchers found out why and determined how to make the nanoparticles effective against ovarian cancer cells.
Nonverbal learning disability (NVLD), a poorly understood and often-overlooked disorder that causes problems with visual-spatial processing, may affect nearly 3 million children in the United States, making it one of the most common learning disorders, according to a new study by led by Columbia University Irving Medical Center.
› Verified 6 days ago